InTrack Investment Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

InTrack Investment Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$530K	Buy	3,349 +374	+13%	+$50.6K	0.26%	81
2026 Q1	$380K	Buy	+2,975	New	+$371K	0.22%	88
2023 Q1	–	Sell	-2,424	Closed	-$201K	–	133
2022 Q4	$201K	Buy	+2,424	New	+$196K	0.2%	119
2022 Q1	–	Sell	-2,582	Closed	-$289K	–	128
2021 Q4	$289K	Sell	2,582 -597	-19%	-$72K	0.2%	104
2021 Q3	$412K	Sell	3,179 -1,053	-25%	-$136K	0.3%	92
2021 Q2	$565K	Buy	+4,232	New	+$556K	0.44%	74

Other funds holding XBI

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

PSP Research Newtown Square, Pennsylvania $188M AUM

AAS

Annex Advisory Services Brookfield, Wisconsin $5.86B AUM 21.83% 1-Year Est. Return

WAM

Weatherly Asset Management Del Mar, California $1.4B AUM 36.32% 1-Year Est. Return

RFM

Royal Fund Management Lady Lake, Florida $1.2B AUM 32.21% 1-Year Est. Return

MFS

Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $132M AUM 24.1% 1-Year Est. Return

EWM

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

LHWM

Lake Hills Wealth Management Austin, Texas $220M AUM 39.11% 1-Year Est. Return

MWA

MFA Wealth Advisors Pittsburgh, Pennsylvania $587M AUM 27.44% 1-Year Est. Return

InTrack Investment Management's XBI Position: Q2 2026 in Review

InTrack Investment Management increased its State Street SPDR S&P Biotech ETF (XBI) stake by 13% in Q2 2026, buying an estimated $50.6K and bringing the position to 3,349 shares worth $530K. The position accounts for 0.26% of the portfolio, ranked #81.

InTrack Investment Management first reported a position in XBI in Q2 2021 and has held it in 6 quarters since. The position peaked at $565K in Q2 2021. 201 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

InTrack Investment Management held 3,349 shares of State Street SPDR S&P Biotech ETF worth $530K as of Q2 2026.
InTrack Investment Management bought 374 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $50.6K.
State Street SPDR S&P Biotech ETF made up 0.26% of InTrack Investment Management's portfolio in Q2 2026, its #81 holding.
InTrack Investment Management first reported a position in State Street SPDR S&P Biotech ETF in Q2 2021 and has held it in 6 quarters since.
InTrack Investment Management's State Street SPDR S&P Biotech ETF position peaked at $565K in Q2 2021.
201 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on InTrack Investment Management's 13F filing for Q2 2026, filed 17 Jul 2026.